Vital KSK Holdings Incorporation operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vital KSK Holdings Incorporation with three other
drug stores in Asia:
Hokuyaku Takeyama Holdings, Inc
sales of 225.15 billion Japanese Yen [US$2.03 billion]
of which 72%
was Pharmaceutical Business),
China National Medicines Corp., Ltd.
(13.39 billion Chinese Renmimbi [US$1.94 billion]
of which 97%
was business department), and
Huadong Medicine Company Limited
based in China
(25.38 billion Chinese Renmimbi [US$3.69 billion]
of which 79%
Vital KSK Holdings Incorporation reported sales of ¥621.04 billion (US$5.59 billion)
March of 2016.
increase of 13.3%
versus 2015, when the company's sales were ¥548.01 billion.
Sales of Other saw an increase
21.7% in 2016, from
¥23.97 billion to ¥29.17 billion.